๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nanjing
Clinical trial register · China

Clinical Trials in Nanjing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University201 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School89 Nanjing First Hospital, Nanjing Medical University68 The Second Hospital of Nanjing Medical University32 Nanjing Medical University30
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Nanjing

1193 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Nudge-Based Exercise Intervention for Adolescents With Obesity
NCT07824453Pediatric Obesity
Nanjing Children's Hospital
Not applicable
140
Nanjing
2026-07-01
Not yet open
Anti-Bloating Patch for Postoperative Gastric Distension After Cardiac Surgery
NCT07677423Postoperative Gastric Distension, Postoperative Gastrointestinal Dysfunction, Cardiac Surgery
Southeast University, China
Not applicable
150
Nanjing
2026-07-01
Not yet open
Clinical Efficacy and Safety of Jingfang Granules in Treating Diarrhea-Predominant Irritable Bowel Syndrome With Cold-Dampness Disturbing Spleen Syndrome
NCT07688161Diarrhea-predominant Irritable Bowel Syndrome
Nanjing First Hospital, Nanjing Medical University
Phase 3
106
Nanjing
2026-07
Not yet open
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer
NCT07690878Bladder Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
35
Nanjing
2026-07
Not yet open
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors
NCT07738679Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
127
Beijing, Lanzhou, Guangzhou, Anyang, Luoyang, Zhengzhou, Nanjing, Xuzhou
2026-07
Recruiting
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
NCT07719140Childhood-onset Systemic Lupus Erythematosus, Lupus Nephritis (LN)
Peking Union Medical College Hospital
Phase 4
198
Beijing, Chongqing, Shenzhen, Changsha, Nanjing, Changchun, Shanghai
2026-07
Not yet open
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
NCT07674147Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory Myopathies
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
30
Nanjing, Hangzhou
2026-07
Not yet open
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
NCT07323095Chronic Kidney Disease
Atom Therapeutics Co., Ltd
Phase 2
80
Beijing, Nanjing, Shanghai, Hangzhou
2026-06-30
Recruiting
Study on the Thrombolytic Effect of Platelet Membrane Coated Tenecteplase on Human Arterial Thrombus
NCT07712445Arterial Thrombosis
The First Affiliated Hospital with Nanjing Medical University
Observational
24
Nanjing
2026-06-30
Active, closed
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
NCT07662122Obesity, Overweight
Boehringer Ingelheim
Phase 2
342
Huzhou, Jinan, Luoyang, Nanjing, Ningbo, Qinhuangdao, Tianjin, Yichang
2026-06-30
Recruiting
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
NCT07555938Multiple Myeloma
Hoffmann-La Roche
Phase 3
380
Guangzhou, Nanjing, Qingdao, Kunming, Hangzhou, Jinan, Nanning, Shanghai
2026-06-23
By invitation
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy๏ผˆPRECAL๏ผ‰
NCT07721441Ulcerative Colitis (UC)
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xiโ€™an
2026-06-18
Recruiting
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
NCT07554339Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
310
Hefei, Beijing, Xiamen, Nanning, Shijiazhuang, Wuhan, Changsha, Nanjing
2026-06-18
Recruiting
Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
NCT07726940Acute Respiratory Distress Syndrome (ARDS)
Southeast University, China
Observational
1,776
Beijing, Fuzhou, Nanjing, Jinan, Chengdu, Hangzhou, Changchun, Chenzhou
2026-06-16
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals
Phase 3
460
Hefei, Guangzhou, Wuhan, Nanjing, Nantong, Changchun, Jinan, Yantai
2026-06-16
Recruiting
CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
NCT07615348Metastatic Clear Cell Renal Cell Carcinoma
Jinling Hospital, China
Phase 2
75
Nanjing, Wuxi
2026-06-16
Not yet open
A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance
NCT07622550Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital
Phase 2
80
Changzhou, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Wuxi, Xuzhou
2026-06-15
Recruiting
Effectiveness and Safety of the Ultheraยฎ System for Skin Laxity in the Lower Face, Submentum and Neck
NCT07614997Cutis Laxa
Merz North America, Inc.
Not applicable
218
Beijing, Guangzhou, Nanjing, Xi'an, Shanghai
2026-06-15
Not yet open
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease
NCT07647133Chronic Kidney Disease
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
249
Shenzhen, Nanjing
2026-06-15
Not yet open
Gastric Feeding for the Prevention of Stroke-Associated Pneumonia
NCT07630090Stroke
Jinling Hospital, China
Phase 4
174
Nanjing
2026-06-15
Not yet open
A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)
NCT07663838Randomized, Open-label, Safety, Tolerability
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
30
Beijing, Nanjing, Nanchang, Changchun, Jinan, Taiyuan, Tianjin
2026-06-15
Not yet open
Health Behavior Intervention for Colorectal Cancer Patients
NCT07632313Colorectal Cancer
Nanjing Medical University
Not applicable
40
Nanjing
2026-06-15
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Lanzhou, Nanchang, Nanjing
2026-06-11
Recruiting
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
NCT07517042Obesity, Weight Control
Shanghai Zhongshan Hospital
Not applicable
420
Chongqing, Fuzhou, Xiamen, Wuhan, Nanjing, Suzhou, Shanghai, Luzhou
2026-06-10
Not yet open
Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL๏ผšStop Trial 2.0
NCT07682415CLL / SLL
Yi Shuhua
Phase 2
60
Shenzhen, Zhengzhou, Changsha, Nanjing, Nanchang, Jinan, Tianjin
2026-06-08
Recruiting
A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.
NCT07622836TNBC, Adjuvant Therapy, Lymph Node Positive
The First Affiliated Hospital with Nanjing Medical University
Not applicable
59
Nanjing
2026-06-05
Recruiting
An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer
NCT07589569Pancreatic Cancer
Shandong Suncadia Medicine Co., Ltd.
Phase 2
92
Nanjing, Tianjin
2026-06-04
Recruiting
A Phase I Study of JSKN021 in Advanced Solid Tumors
NCT07617727Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1
199
Fuzhou, Nanning, Harbin, Wuhan, Nanjing, Xuzhou, Jining, Shanghai
2026-06-02
Not yet open
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCL
NCT07643805DLBCL
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2
46
Nanjing
2026-06-01
Active, closed
The Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury
NCT07602465Acute Kidney Injury (AKI)
Zhongda Hospital
Observational
5,000
Nanjing
2026-06-01
Recruiting
Epidural Spinal Cord Stimulation for Respiratory Recovery in Cervical SCI
NCT07722130Spinal Cord Injury Cervical, Respiratory Failure
Zhongda Hospital
Not applicable
20
Nanjing
2026-06-01
Recruiting
The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment
NCT07650318Type 2 Diabetes Mellitus (T2DM), Mild Cognitive Impairment (MCI)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
40
Nanjing
2026-06-01
Recruiting
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naรฏve, High-Risk CLL/SLL Patients
NCT07671378CLL (Chronic Lymphocytic Leukemia)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
24
Nanjing
2026-06-01
Recruiting
Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
NCT07672860Kidney Cancer
Jinling Hospital, China
Phase 2
146
Nanjing
2026-06-01
Not yet open
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism
NCT07603700Pulmonary Embolism, Venous Thromboembolism
Nanjing First Hospital, Nanjing Medical University
Observational
1,300
Nanjing
2026-06-01
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
NCT06712654Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis
R1 Therapeutics
Phase 2
168
Beijing, Zhengzhou, Nanjing, Shanghai, Chengdu
2026-06-01
Recruiting
Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
NCT07611825Advanced RCC
Jinling Hospital, China
Phase 2
33
Nanjing
2026-06-01
Active, closed
AI-CCTA for Predicting Cardiovascular Events in CAD
NCT07832175Coronary Artery Disease, Atherosclerotic Cardiovascular Disease
Nanjing First Hospital, Nanjing Medical University
Observational
3,000
Nanjing
2026-06-01
Recruiting
Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes
NCT07608978Diffuse Large B-Cell Lymphoma (DLBCL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
35
Nanjing
2026-06-01
Not yet open
Intranasal Dexmedetomidine or Esketamine for Negative Postoperative Behavioral Changes in Children
NCT07570160Behavior Problem
Nanjing Children's Hospital
Phase 4
342
Nanjing
2026-06-01
Not yet open
Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis
NCT07642544Psoriasis, Psoriasis (PsO)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
120
Nanjing
2026-06-01
By invitation
Effect of Liposomal Bupivacaine and Bupivacaine Hydrochloride for Superior Trunk Block of the Interscalene Brachial Plexus on Postoperative Diaphragmatic Function and Analgesia
NCT07587203Proximal Humerus Surgery, Rotator Cuff Surgery, Shoulder Arthroplasty, Shoulder Arthroscopy
Nanjing First Hospital, Nanjing Medical University
Not applicable
184
Nanjing, Suzhou
2026-06-01
Recruiting
Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
NCT07663253Multiple Myeloma
Shanghai Zhongshan Hospital
Observational
333
Beijing, Guangzhou, Shenzhen, Naning, Harbin, Zhengzhou, Wuhan, Nanjing
2026-06
Recruiting
Undergraduate Nursing Intern Cohort Study
NCT07682493Occupational Disidentification
Nanjing Medical University
Observational
500
Nanjing
2026-06
Not yet open
Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy
NCT07627464Renal Cell Carcinoma (RCC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
144
Beijing, Changchun, Changsha, Hangzhou, Kunming, Nanjing, Nanning, Qingdao
2026-05-31
Not yet open
Perioperative Vericiguat in Patients Undergoing Cardiovascular Surgery
NCT07594509Cardio Vascular Disease, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
600
Nanjing
2026-05-31
Not yet open
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer
NCT07446387Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital
Phase 2
70
Nanjing
2026-05-30
Not yet open
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
NCT07582822Advanced Solid Tumor
Biotech Pharmaceutical Co., Ltd.
Phase 1
60
Chongqing, Zhengzhou, Changsha, Nanjing, Xi'an, Shanghai, Taiyuan, Chengdu
2026-05-30
Not yet open
A Study on the Efficacy of Sodium Propionate Combined With Anti-PD-1 Immunotherapy in Gastric Cancer
NCT07615907Gastric Cancer (GC)
Jinling Hospital, China
Not applicable
20
Nanjing
2026-05-30
Not yet open
Efficacy and Safety of Transcranial Temporal Interference Stimulation for Depression
NCT07612501Major Depressive Disorder (MDD)
Yonggui Yuan
Not applicable
60
Nanjing
2026-05-30
Recruiting
Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings
NCT07620223Hepatobiliary Surgery, Prophylactic Antibiotics
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
378
Nanjing
2026-05-24
Recruiting
Multicenter Validation of a Risk Prediction Model for MDRGNB Infection
NCT07603128Infection
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,000
Nanjing, Ankang, Datong, Ganzhou, Hangzhou, Huaian, Nanning, Shanghai
2026-05-22
Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
NCT07413939HER2-positive Breast Cancer
Hoffmann-La Roche
Phase 2/3
650
Nanjing, Shanghai, Beijing, Bengbu, Chengdu, Fuzhou, Guangzhou, HangzhouZhejiang
2026-05-21
Recruiting
Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC
NCT07646639Rectal Cancer, Radiotherapy
The First Affiliated Hospital with Nanjing Medical University
Phase 2
122
Nanjing
2026-05-20
Recruiting
Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer
NCT07616427HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
100
Nanjing, Hangzhou, Ningbo
2026-05-20
Recruiting
Adaptive DBS for PD
NCT07635823Parkinson Disease(PD)
Beijing Pins Medical Co., Ltd
Not applicable
60
Hefei, Beijing, Guangzhou, Changsha, Nanjing, Jinan, Chengdu
2026-05-16
Recruiting
The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
NCT07596654Esophageal Carcinoma, Limited-Stage Small Cell Esophageal Carcinoma
yi shen
Observational
4
Nanjing
2026-05-15
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
NCT07607275Hypertension, Essential (Primary) Hypertension
Beijing Anzhen Hospital
Phase 4
350
Beijing, Chongqing, Dalian, Hohhot, Longyan, Luohe, Nanchang, Nanjing
2026-05-15
Recruiting
A Phase โ…ก/โ…ข Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
NCT07462143Colorectal (Colon or Rectal) Cancer
RemeGen Co., Ltd.
Phase 2/3
80
Beijing, Chongqing, Fuzhou, Meizhou, Nanjing, Shijiazhuang, Zhengzhou, Wuhan
2026-05-12
Recruiting
Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis
NCT07592585Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3
360
Nanjing
2026-05-12
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001Obesity, Heart Failure
Novo Nordisk A/S
Phase 3
5,610
Guangzhou, Shijiazhuang, Harbin, Changsha, Baotou, Changzhou, Nanjing, Suzhou
2026-05-11
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT07517263Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals
Phase 3
5,700
Beijing, Lanzhou, Foshan, Guangzhou, Harbin, Changsha, Baotou, Nanjing
2026-05-11
Recruiting
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
NCT07558850Rheumatoid Arthritis, Dermatomyositis, Systemic Lupus Erythematosus, Systemic Sclerosis
The First Affiliated Hospital with Nanjing Medical University
Not applicable
72
Nanjing
2026-05-10
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention
NCT07630597Obesity & Overweight
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
24
Nanjing
2026-05-08
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
NCT07415031Solid Tumors
Mirati Therapeutics Inc.
Phase 2
170
Beijing, Xiamen, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang, Jinan
2026-05-06
Recruiting
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
NCT07571551Clear Cell RCC
Jinling Hospital, China
Phase 2
75
Nanjing
2026-05-06
Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
NCT07549412Metastatic Colorectal Cancer
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Guangzhou, Nanning, Wuhan, Nanjing, Chengdu, Hangzhou
2026-05-06
Recruiting
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571005Obesity, Overweight, Obstructive Sleep Apnoea
Novo Nordisk A/S
Phase 3
300
Beijing, Nanjing, Suzhou, Zhenjiang, Huzhou
2026-05-05
Recruiting
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571109Obesity, Overweight, Obstructive Sleep Apnoea
Novo Nordisk A/S
Phase 3
300
Beijing, Guangzhou, Shenzhen, Luoyang, Nanjing, Tianjin
2026-05-05
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Phase 3
670
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanjing
2026-05-04
Not yet open
Neoadjuvant SHR-A1811 and SHR-A1701 for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma
NCT07581574Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 1
12
Nanjing
2026-05-01
Not yet open
Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC
NCT07523789TNBC, Triple Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Observational
201
Nanjing
2026-05-01
Not yet open
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
NCT07550894Acute Kidney Injury, Sepsis, Critically Ill Patients Requiring Continuous Renal Replacement Therapy
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou, Nanning, Luoyang, Zhengzhou, Wuhan, Nanjing, Xi'an
2026-05-01
Recruiting
Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive Impairment
NCT07603102Stroke, Mild Cognitive Impairment (MCI)
Nanjing Mingzhou Rehabilitation Hospital
Not applicable
60
Nanjing
2026-05-01
Not yet open
Prospective International Multi-center Clinical Trial of PGT-A Upgrade
NCT07533630Infertility Assisted Reproductive Technology
Reproductive & Genetic Hospital of CITIC-Xiangya
Observational
1,700
Changsha, Nanjing, Kunming
2026-05
Recruiting
A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
NCT07532538Hypopharyngeal Cancer, Laryngeal Cancer, Head and Neck Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
3,000
Nanjing
2026-04-30
Not yet open
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
NCT07566065Atherosclerotic Renal Artery Stenosis, Hypertension, Renal Artery Stenosis
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
150
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Jinan, Qingdao
2026-04-30
Recruiting
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
NCT07404553Hypercholesterolemia
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 2/3
126
Nanjing
2026-04-30
Recruiting
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
NCT07548996Type 1 Diabetes Mellitus
Nanjing Medical University
Phase 2/3
96
Nanjing
2026-04-27
Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
NCT07419295Bladder Cancer
Merck Sharp & Dohme LLC
Phase 3
590
Beijing, Chongqing, Guangzhou, Zhuhai, Wuhan, Changsha, Nanjing, Nanchang
2026-04-23
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
By invitation
CHT105 for the Treatment of Refractory Lupus Nephritis
NCT07517536Systemic Lupus Erythematosus, Lupus Nephritis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
14
Nanjing
2026-04-22
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT07365995Metastatic Castration-resistant Prostate Cancer
BioNTech SE
Phase 3
736
Changsha, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai, Wenzhou, Wuhan
2026-04-22
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232Crohn Disease
Janssen Research & Development, LLC
Phase 3
530
Changzhou, Chongqing, Guangzhou, Nanjing, Wuhan
2026-04-21
Recruiting
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
NCT07409181Systemic Lupus Erythematosus
Boehringer Ingelheim
Phase 2
405
Beijing, Changchun, Changsha, Guangzhou, Linfen, Nanjing, Ningbo, Shanghai
2026-04-20
Recruiting
QUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast Cancer
NCT07601178TNBC, Triple Negative Breast Cancer
Jiangsu Cancer Institute & Hospital
Phase 2
34
Nanjing
2026-04-17
Recruiting
A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China
NCT07588880Progressive Familial Intrahepatic Cholestasis
Ipsen
Observational
20
Beijing, Chongqing, Hunan, Nanjing, Shanghai, Xiamen
2026-04-16
Recruiting
Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)
NCT07496229T-cell Lymphomas
Dizal Pharmaceuticals
Phase 1/2
165
Chongqing, Fuzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Chengdu, Taizhou
2026-04-15
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
NCT07541521Stage IIB-III NSCLC, Sleeve Lobectomy, Robotic Surgery, Neoadjuvant Chemoimmunotherapy
Shanghai Chest Hospital
Observational
100
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-04-13
Active, closed
A Study of SYH2082 Injection in Healthy Participants
NCT07736404Overweight or Obesity
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1
50
Nanjing
2026-04-13
Active, closed
A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents
NCT07472725Diabetes Mellitus, Type 2
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
102
Shenzhen, Nanjing
2026-04-11
By invitation
A Post-marketing Observational Study of Oral Cholera Vaccine
NCT07300462Diarrhea
Shanghai United Cell Biotechnology Co., Ltd
Phase 4
6,000
Hefei, Beijing, Wuhan, Nanjing, Jinan
2026-04-10
Recruiting
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
NCT07479485Hepatocellular Carcinoma
Lepu Biopharma Co., Ltd.
Phase 1/2
160
Beijing, Fuzhou, Zhengzhou, Nanjing, Tianjin, Lishui
2026-04-08
Recruiting
SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer
NCT07464756Gastric Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
80
Nanjing
2026-04-03
Active, closed
A Study of CS060380 Tablets in Patients With MASH and Obesity
NCT07466017Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity
Cascade Pharmaceuticals, Inc
Phase 2
130
Hefei, Guangzhou, Shijiazhuang, Nanjing, Shanghai, Hangzhou, Ningbo, Wenzhou
2026-04-02
Recruiting
Effects and Mechanisms of Transcranial Direct Current Stimulation Combined With Dialectical Behavior Therapy Skills Training in Adults With Attention-Deficit/Hyperactivity Disorder
NCT07565402Adult Attention Deficit Hyperactivity Disorder
Nanjing Medical University
Not applicable
60
Nanjing
2026-04-01
Not yet open
Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
NCT07451665Takayasu Arteritis (TAK)
Chinese SLE Treatment And Research Group
Phase 4
180
Beijing, Guanzhou, Shenzhen, Nanning, Jiaozuo, Luoyang, Wuhan, Nanjing
2026-04-01
Not yet open
Remote Ischemic Conditioning for Cognitive Impairment in Cerebral Small Vessel Disease
NCT07317557Cerebral Small Vessel Disease, Cognitive Impairment
Jiangsu Province Nanjing Brain Hospital
Not applicable
40
Nanjing
2026-04-01
Recruiting
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
NCT07558863Type 2 Diabetes, Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University
Phase 4
60
Nanjing
2026-04-01
Not yet open
First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
NCT07516639Healthy Subjects (HS), SLE (Systemic Lupus)
SUNHO๏ผˆChina๏ผ‰BioPharmaceutical CO., Ltd.
Phase 1
26
Nanjing
2026-04-01
Rows per page Showing 101–200 of 1193
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/nanjing?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,193 of those studies with a site in Nanjing.

How many clinical trials are recruiting in Nanjing?

713 of the 1,193 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 232 have not yet opened recruitment, 216 are active but closed to new participants, and 32 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.